Skip to content

Retinoblastoma specific cohort study

Retinoblastoma specific cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-EOC-17013371
Enrollment
Unknown
Registered
2017-11-14
Start date
2017-12-01
Completion date
Unknown
Last updated
2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retinoblastoma

Interventions

Case series:IAC

Sponsors

Guangzhou Women and Children Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 99 Years

Inclusion criteria

Inclusion criteria: (1) retinoblastoma patients; (2) Volunteer to participate in our study and sign the informed consent. ;Inclusion criteria: (1) retinoblastoma patients; (2) Volunteer to participate in our study and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Diagnosis unclear,document uncomplete; (2) Have other serious eye diseases; (3) There are serious systemic diseases including abnormal liver and kidney function, abnormal blood routine and coagulation function, and congenital heart disease patients and people with hearing disabilities.;Exclusion criteria: (1) Diagnosis unclear,document uncomplete; (2) Have other serious eye diseases; (3) There are serious systemic diseases including abnormal liver and kidney function, abnormal blood routine and coagulation function, and congenital heart disease patients and people with hearing disabilities.

Design outcomes

Primary

MeasureTime frame
Globe salvage rate;;Globe salvage rate;

Countries

China

Contacts

Public ContactZhang Jing;Zhang Jing ;

Guangzhou Women Childrens Medical Center;Guangzhou Women Childrens Medical Center

fejr@foxmail.com;fejr@foxmail.com+86 13826282846;+86 13826282846

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026